The HAART Observational Medical Evaluation and Research (HOMER) study is a retrospective cohort of HIV-positive individuals receiving HAART in British Columbia. Started on August 1, 1996, the cohort follows HIV-infected individuals in the Drug Treatment Program who initiated HAART with three or more antiretroviral agents. This cohort has formed the basis of studies published in AIDS, JAIDS, JAMA, and The Lancet, among others.
